Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00769561
Other study ID # TMD_Jue2008
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received October 8, 2008
Last updated December 4, 2013
Start date August 2008
Est. completion date April 2011

Study information

Verified date December 2013
Source Philipps University Marburg Medical Center
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

The purpose of this study is to develop and evaluate a biofeedback-based cognitive behavioral treatment for patients with chronic temporomandibular disorders using a randomized controlled design.


Description:

The purpose of this study is to develop and evaluate a biofeedback-based cognitive behavioral treatment for temporomandibular disorders using a randomized controlled design. 100 patients suffering from chronic temporomandibular disorder are diagnosed using Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD). Subsequently, patients are randomly assigned to either a psychological intervention receiving 8 sessions of biofeedback-based cognitive behavioral treatment or to a dental intervention receiving interocclusal splint therapy.

Assessment takes place at baseline, after treatment approximately 8 weeks later, 3 and 6 months follow up. The effects of the interventions are evaluated in terms of reduction in pain intensity, pain related disability, psychological variables such as somatoform symptoms, depression and pain related cognitive adjustment as well as nocturnal electromyographic (EMG) activity.

Additionally, the study aims at identifying variables that predict treatment outcome. Further analyses include initial changes in treatment motivation and illness perceptions and its influence on treatment success, as well as changes in psychophysiological stress reactivity through treatment.


Recruitment information / eligibility

Status Completed
Enrollment 58
Est. completion date April 2011
Est. primary completion date July 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- clinical diagnosis of painful temporomandibular disorder according to Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD)

- symptoms persist at least 3 months

- sufficient language skills

Exclusion Criteria:

- somatic diagnosis that requires defined somatic treatment (e.g. occlusal interference)

- presence of a psychotic disorder

- presence of neurological disorders (e.g. dementia)

- alcohol or substance abuse

- presence of other pain condition of predominant severity

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Biofeedback-Based Cognitive Behavioral Treatment
The biofeedback-based cognitive behavioral intervention comprises 8 individual sessions, each containing both cognitive behavioral and biofeedback elements. Treatment elements are education about the disorder, biofeedback training aimed at improving proprioceptive awareness and reversing parafunctional habits, relaxation techniques, and stress management. Furthermore patients receive portable biofeedback devices for EMG-biofeedback training during day and nighttime in order to reverse diurnal and nocturnal bruxing habits.
Device:
Dental treatment with occlusal splint (OS)
Maxillary or mandibular occlusal splints are made of hard acrylic after taking impressions of the upper and lower dental arches, face bow registration and recording of centric relation. Splints are adjusted to provide even occlusal contact during jaw closing and chewing, and canine and incisor contact during protrusive movements of the jaw. Patients are instructed to use the splint each night and during day time for a period of 7 weeks. One week after initial insertion of the splint patients are requested to return for adjustment.

Locations

Country Name City State
Germany Department of Clinical Psychology and Psychotherapy, Philipps University Marburg Marburg
Germany Department of Oral and Maxillofacial Surgery, Philipps University Marburg Medical Center Marburg

Sponsors (2)

Lead Sponsor Collaborator
Philipps University Marburg Medical Center Psychotherapie-Ambulanz Marburg e.V.

Country where clinical trial is conducted

Germany, 

References & Publications (3)

Shedden Mora M, Weber D, Borkowski S, Rief W. Nocturnal masseter muscle activity is related to symptoms and somatization in temporomandibular disorders. J Psychosom Res. 2012 Oct;73(4):307-12. doi: 10.1016/j.jpsychores.2012.07.008. Epub 2012 Aug 29. — View Citation

Shedden Mora MC, Weber D, Neff A, Rief W. Biofeedback-based cognitive-behavioral treatment compared with occlusal splint for temporomandibular disorder: a randomized controlled trial. Clin J Pain. 2013 Dec;29(12):1057-65. doi: 10.1097/AJP.0b013e3182850559 — View Citation

Shedden Mora, M., Bleichhardt, G., Weber, D., Neff, A., & Rief, W. (2010). Biofeedback bei kraniomandibulären Dysfunktionen. Psychotherapeut, 55(3), 217-224.

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Intensity (German Pain Questionnaire; Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD)) Characteristic pain intensity (German Pain Questionnaire; Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD)):
Characteristic pain intensity was calculated by averaging ratings of current pain, average pain, and worst pain in the past month on a numeric rating scale from 0 (no pain) to 10 (maximum pain), as recommended by RDC/TMD (range 0 - 10). Higher values indicate higher pain levels.
Pre-Post-Design including 3 assessment points: pre-treatment, post-treatment (after 8 weeks), and 6-month follow up No
Primary Pain Disability (Pain Disability Index) Pain related disability was assessed using the Pain Disability Index (PDI). The PDI is a brief self-rating scale which assesses the level of pain related disability in seven areas of daily life (e.g., social activity, self-care) on a 0 (no disability) -10 (maximum disability) numeric rating scale (range 0 - 70). Higher values indicate higher disability levels. Cronbach's alpha was .87 in the current sample. Pre-Post-Design including 3 assessment points: pre-treatment, post-treatment (after 8 weeks), and 6-month follow up No
Primary Jaw Use Limitations (JDL) Jaw use limitations were measured using the Jaw Disability List (JDL) from the RDC/TMD. The JDL asks the patient to rate interference with eleven oral activities, for example chewing or talking. We used an 11-point numeric rating scale (from 0 'no limitation' to 10 'maximum limitation') instead of ratings of 'yes' and 'no' (range 0 - 110). Higher values indicate higher levels of jaw use limitations. Cronbach's alpha was .86 in the current sample. Pre-Post-Design including 3 assessment points: pre-treatment, post-treatment (after 8 weeks), and 6-month follow up No
Secondary Somatoform Symptoms (Screening for Somatoform Disorders, SOMS) Somatoform complaints during the past week were assessed using the Screening for Somatoform Symptoms (SOMS-7). 32 medically unexplained symptoms (29 for male subjects) representing DSM-IV criteria for somatization disorder were rated on a 0 ('not at all') to 4 ('very much') scale (range 0 - 128 for women and 0 - 116 for men). A sum score was calculated with higher scores indicating higher intensity and burden of somatoform complaints. In the current sample, Cronbach's alpha level was a = .88. Pre-Post-Design including 3 assessment points: pre-treatment, post-treatment (after 8 weeks), and 6-month follow up No
Secondary Depressive Symptoms (Centers for Epidemiologic Studies Depression Scale) Depressive symptoms were measured using the Centre for Epidemiological Studies Depression scale (CES-D). The CES-D asks for the frequency of 20 symptoms of depression during the past week on a scale ranging from 0 ('less than 1 day') to 3 ('5 to 7 days') (range 0-60). Higher scores indicate more depressive symptoms. It is suitable for use in chronic pain patients as it relies less on physical symptoms of depression than do other measures. Cronbach's alpha level in the current sample was a = .89. Pre-Post-Design including 3 assessment points: pre-treatment, post-treatment (after 8 weeks), and 6-month follow up No
Secondary General Anxiety Symptoms (GAD-7) General anxiety symptoms were assessed using the 7-item scale from the Patient Health Questionnaire (GAD-7). The GAD-7 asks for anxiety symptoms during the past month on a 1 ('not at all') to 3 ('more than half of the days') rating scale (range 7-21). Higher scores indicate higher levels of anxiety. Cronbach's alpha level in the current sample was a = .64. Pre-Post-Design including 3 assessment points: pre-treatment, post-treatment (after 8 weeks), and 6-month follow up No
Secondary Pain Coping (FESV) Cognitive and behavioral pain coping strategies were assessed with Coping Strategies Scale from the German Pain Coping Questionnaire (Fragebogen zur Erfassung der Schmerzverarbeitung, FESV). The scale asks for the use of 24 cognitive (e.g. cognitive restructuring) and behavioral (e.g. use of relaxation techniques) strategies for coping with pain on a scale ranging from 1 ('fully disagree') to 6 ('fully agree') (range 24-144). A sum score was used with higher scores indicating more adaptive coping. Cronbach's alpha level was a = .80. Pre-Post-Design including 3 assessment points: pre-treatment, post-treatment (after 8 weeks), and 6-month follow up No
Secondary TMD Related Symptoms TMD related symptoms, such as jaw pain, toothache or dizziness, were measured using a 41-item TMD symptom list. Following the SOMS-7 scale, intensity of symptoms experienced during the past week was rated from 0 ('not at all') to 4 ('very high intensity') (range 0 - 164). A sum score was built with higher scores indicating higher intensity of TMD related symptoms. The TMD symptom list has not been evaluated previously; however, large bivariate correlations with somatization (Pearson's r = .79), medium to large correlations with pain intensity (r = .48), and medium correlations with depression (r = .37) and anxiety (r = .27) provide evidence of good convergent and divergent validity. Cronbach's alpha level in the current sample was excellent (a = .93). Pre-Post-Design including 3 assessment points: pre-treatment, post-treatment, and 6-months follow up No
See also
  Status Clinical Trial Phase
Completed NCT02839967 - Influence of Intraoral Photobiomodulation in Individuals With Temporomandibular Joint Dysfunction N/A
Completed NCT01659840 - Efficacy of Red and Infrared Lasers in Treatment of Temporomandibular Disorders N/A
Recruiting NCT05720065 - Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A Phase 2
Completed NCT03339739 - Effects of Mandibular Exercises Effect on Pain Perception and Sensitivity in Mandibular Myofascial Pain N/A
Recruiting NCT03029494 - Oxidative Stress and Opiorphin in Temporomandibular Disorders N/A
Completed NCT05607823 - Adding Core Stabilization Training to Manuel Therapy in Temporomandibular Disorders N/A
Completed NCT04948320 - Temporomandibular Dysfunction Affects Neck Disability, Headache, Anxiety, And Sleep Quality In Women: A Cross-Sectional Study
Recruiting NCT04726683 - Dry Needling vs Injection in Patients With Temporomandibular Disorders N/A
Completed NCT01201512 - CONDOR Temporomandibular Muscle and Joint Disorders (TMJD) Survey N/A
Completed NCT04098952 - Effects of Electric Massage on the Cervical Region in Subjects Diagnosed With Temporomandibular Disorders N/A
Terminated NCT05162027 - Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE) Phase 2
Completed NCT03926767 - Additional Effect of Pain Neuroscience Education to Orofacial and Neck Exercises in Temporomandibular Disorders N/A
Recruiting NCT05902026 - The BETY-Biopsychosocial Questionnaire (BETY-BQ) in Individuals With Temporomandibular Dysfunction-Related Headache
Completed NCT03736408 - Frequency of Occurrence of the Pain Form of Temporomandibular Joint Dysfunction
Recruiting NCT04694274 - Genetic Polymorphisms and Their Association With Temporomandibular Disorders
Recruiting NCT01544439 - Occlusal Splint and Counseling to Temporomandibular Disorder Phase 3
Completed NCT01535378 - Interest of Behavioural Reeducation in Dysfunctions of Masticatory Apparatus. Relations Between Parafunctions and Dysfunctions of Mastixatory Apparatus N/A
Completed NCT02380105 - Effectiveness of a Counseling Program for Temporomandibular Disorders (TMD) Treatment N/A
Completed NCT02230371 - Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles Phase 4
Recruiting NCT03990662 - What Are the Clinical Factors Associated With a Significant Pain Reduction Following Physiotherapy in Patients With Temporomandibular Disorders?